Interrogating Cancer Drivers via CRISPR: Mutant TP53 as a Therapeutic Target in Hypodiploid B-cell Acute Lymphoblastic Leukemia You are invited to a free webinar featuring Dr. Ernesto Diaz-Flores, a pediatric oncologist from the University of California at San Francisco. In this one hour telecast, Dr. Diaz-Flores will speak to the challenges and opportunities behind creating […]

LevitasBio is excited to be a part of EACR 2022 this year.  Our team is looking forward to meeting with you in booth #53 (second floor) to discuss your challenges with dissociated tumor samples and other similar sample types. Come by and learn how levitation technology may be the solution you have been looking for!

LevitasBio is excited to be a part of the British Association for Cancer Research!  Come by and learn more about our disruptive solutions and how they have impacted cancer research.  We look forward to meeting you at booth #3.